Journal of Hospital Infection
Volume 76, Issue 2 , Pages 124-129 , October 2010

Soft tissue infections related to peripheral intravenous catheters in hospitalised patients: a case–control study

  • W.-L. Lee

      Affiliations

    • Nursing Department, Hsinchu Cathay General Hospital, Hsinchu, Taiwan
    • Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
    • ,
  • S.-F. Liao

      Affiliations

    • Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
    • ,
  • W.-C. Lee

      Affiliations

    • Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
    • ,
  • C.-H. Huang

      Affiliations

    • Division of Infectious Diseases and Infection Control Committee, Cathay General Hospital, Taipei, Taiwan
    • School of Medicine, Fu Jen Catholic University, Taipei, Taiwan
    • ,
  • C.-T. Fang

      Affiliations

    • Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, Taipei, Taiwan
    • Division of Infectious Diseases, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
    • Corresponding Author InformationCorresponding author. Address: Graduate Institute of Epidemiology, College of Public Health, National Taiwan University, 17 Xu-Zhou Road, Taipei, Taiwan. Tel.: +886 2 33668035; fax: +886 2 23952133.

Received 24 February 2010 ,Accepted 20 May 2010.

References 

  1. Kagel EM, Rayan GM. Intravenous catheter complications in the hand and forearm. J Trauma. 2004;56:123–127
  2. Pratt RJ, Pellowe CM, Wilson JA, et al. Epic2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2007;65S:S1–64
  3. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med. 2000;162:1027–1030
  4. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001;136:229–234
  5. O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Morb Mortal Wkly Rep. 2002;51(RR-10):1–26
  6. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing, a meta-analysis of the infection risks. J Am Med Assoc. 1992;267:2072–2076
  7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:28–40
  8. Coughlin SS, Benichou J, Weed DL. Attributable risk estimation in case–control studies. Epidemiol Rev. 1994;16:51–64
  9. Rothman KJ. Cause. Am J Epidemiol. 1976;104:587–592
  10. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339–343
  11. Darouiche RO, Wall MJ, Itani KM, et al. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med. 2010;362:18–26
  12. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med. 1998;158:473–477
  13. Palefski SS, Stoddard GJ. The infusion nurse and patient complication rates of peripheral-short catheters. J Intraven Nurs. 2001;24:113–123
  14. Lee WL, Chen HL, Tsai TY, et al. Risk factors for peripheral intravenous catheter infection in hospitalized patients: a prospective study of 3165 patients. Am J Infect Control. 2009;37:683–686
  15. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48-vs 72-hour intervals, 72 hours is safe and cost-effective. J Am Med Assoc. 1987;258:1777–1781
  16. Macias AE, de Leon SP, Huertas M, et al. Endemic infusate contamination and related bacteremia. Am J Infect Control. 2008;36:48–53
  17. Playford EG, Looke DFM, Whitby M, Stackelroth J, Harrison K, Watts A. Endemic nosocomial Gram-negative bacteraemias resulting from contamination of intravenous heparin infusions. J Hosp Infect. 1999;42:21–26
  18. Mermei LA. Bacteriology, safety and prevention of infection associated with continuous intravenous infusions. Blood Coagul Fibrinolysis. 1996;7:S45–51
  19. Pittet D. Nosocomial bloodstream infections. In:  Wenzel RP editors. Prevention and control of nosocomial infections. 3rd ed.. Baltimore: Williams & Wilkins; 2005;p. 740–747
  20. Waitt C, Waitt P, Pirmohamed M. Intravenous therapy. Postgrad Med J. 2004;80:1–6
  21. Indar R. The dangers of indwelling polyethylene cannulae in deep veins. Lancet. 1959;1:284–286
  22. Crane C. Venous interruption of septic thrombophlebitis. N Engl J Med. 1960;262:947–951
  23. Brown SL, Morrison AE. Local anesthetic infusion pump systems adverse events reported to the Food and Drug Administration. Anesthesiology. 2004;100:1305–1306
  24. Curran ET, Coia JE, Gilmour H, McNamee S, Hood J. Multi-centre research surveillance project to reduce infections/phlebitis associated with peripheral vascular catheters. J Hosp Infect. 2000;46:194–202

PII: S0195-6701(10)00248-3

doi: 10.1016/j.jhin.2010.05.012

Journal of Hospital Infection
Volume 76, Issue 2 , Pages 124-129 , October 2010

Article Tools